| Affiliation: | 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2. Division of Hematology/Oncology, Department of Medicine, Moores Cancer Center, University of California San Diego, San Diego, CA;3. Department of Cancer Medicine, Institute Gustave Roussy, Paris, France;4. Pfizer Oncology, Pfizer Inc, New York, NY;5. Department of Medicine, Massachusetts General Hospital, Boston, MA;1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;2. Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA;3. Clinical Operations and Program Management, Tokai Pharmaceuticals, Cambridge, MA;4. Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI;5. Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;6. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA;1. Department of Urology, University of Washington School of Medicine, 1959 Northeast Pacific, Seattle, WA 98195, USA;2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA |
